TNPSC Thervupettagam

COVAXIN neutralizes double Mutant Strain

April 29 , 2021 1232 days 779 0
  • The Indian Council of Medical Research recently announced that COVAXIN neutralises the Double Mutant Strain of COVID-19.
  • The National Institute of Virology recently demonstrated the neutralisation potential of COVAXIN against the Brazil variant and UK variant.
  • The B.1.617 is a recently spreading double mutant variant of COVID-19.
  • It carries the mutations of E484Q and also the mutations of L452R.

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories